Table 4.
Multivariable analysis of factors associated with the risk of cardiopulmonary events.
| All patients (n = 290) | Patients without a history of cerebrovascular disease (n = 277) | |
|---|---|---|
| aOR (95% CI) | aOR (95% CI) | |
| STOP-Bang | ||
| STOP-Bang < 3 | 1 | 1 |
| STOP-Bang ≥ 3 | 1.95 (1.07–3.54) | 1.94 (1.06–3.54) |
| Cerebrovascular disease | ||
| No | 1 | – |
| Yes | 0.04 (0.004–0.35) | – |
| COPD | ||
| No | 1 | 1 |
| Yes | 2.30 (1.19–4.47) | 2.42 (1.24–4.75) |
| Chronic kidney disease | ||
| No | 1 | 1 |
| Yes | 5.61 (1.44–21.82) | 6.21 (1.49–25.90) |
| Baseline heart rate,/10 beats/min | 1.23 (0.997–1.52) | 1.19 (0.96–1.47) |
| Baseline SpO2,/% | 0.66 (0.55–0.78) | 0.65 (0.54–0.77) |
| Procedure time,/2 min | 1.14 (1.01–1.30) | 1.16 (1.02–1.31) |
aOR adjusted odds ratio, CI confidence interval, COPD chronic obstructive pulmonary disease, SpO2 pulse oximeter oxygen saturation.